Literature DB >> 22985839

Long-term outcomes of Hirschsprung's disease.

Risto J Rintala1, Mikko P Pakarinen.   

Abstract

Despite significant developments in the understanding of the pathologic anatomy and physiology of Hirschsprung's disease (HD), the results of surgical therapy remain far from perfect. The functional defects and psychosocial difficulties that occur commonly in children with HD are passed on to adulthood in a significant proportion of patients. Recent prospective and adequately controlled cross-sectional studies reveal that constipation and fecal soiling are common late sequelae in adulthood. HD patients show uniformly lower scores of overall bowel function than healthy control subjects. Functional outcome and quality of life may be interrelated and deteriorate with increasing age. Despite these shortcomings, at adult age, most of the HD patients appear to be able to function as normal members of the society in terms of psychosocial, occupational, and recreational activities. Patients are at risk of developing related conditions, such as cancer, that require planning of specific screening programs. Many of the long-term problems that these patients experience are specific to HD. The follow-up of HD patients should be performed by medical personnel familiar with the disease, preferably in a specialized referral center, and the follow-up should continue beyond childhood.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22985839     DOI: 10.1053/j.sempedsurg.2012.07.008

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  32 in total

Review 1.  Redo pullthrough for Hirschsprung disease.

Authors:  Matthew W Ralls; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2016-12-31       Impact factor: 1.827

2.  Prevalence, Risk Factors, and Prognosis of Postoperative Complications after Surgery for Hirschsprung Disease.

Authors:  Wen-Kai Huang; Xue-Li Li; Jin Zhang; Shu-Cheng Zhang
Journal:  J Gastrointest Surg       Date:  2017-09-27       Impact factor: 3.452

Review 3.  The Pediatric Colorectal and Pelvic Learning Consortium (PCPLC): rationale, infrastructure, and initial steps.

Authors:  Ron W Reeder; Richard J Wood; Jeffrey R Avansino; Marc A Levitt; Megan M Durham; Jonathan Sutcliffe; Paola Midrio; Casey M Calkins; Ivo de Blaauw; Belinda Hsi Dickie; Michael D Rollins
Journal:  Tech Coloproctol       Date:  2018-05-04       Impact factor: 3.781

4.  Current status of Hirschsprung's disease: based on a nationwide survey of Japan.

Authors:  Tomoaki Taguchi; Satoshi Obata; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2017-01-05       Impact factor: 1.827

5.  Bowel dysfunction following pullthrough surgery is associated with an overabundance of nitrergic neurons in Hirschsprung disease.

Authors:  Lily S Cheng; Dana M Schwartz; Ryo Hotta; Hannah K Graham; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2016-08-09       Impact factor: 2.545

Review 6.  Stem cell-based therapy for hirschsprung disease, do we have the guts to treat?

Authors:  Ali Fouad Alhawaj
Journal:  Gene Ther       Date:  2021-06-14       Impact factor: 5.250

7.  Human and Murine Tissue-Engineered Colon Exhibit Diverse Neuronal Subtypes and Can Be Populated by Enteric Nervous System Progenitor Cells When Donor Colon Is Aganglionic.

Authors:  Minna M Wieck; Wael N El-Nachef; Xiaogang Hou; Ryan G Spurrier; Kathleen A Holoyda; Kathy A Schall; Salvador Garcia Mojica; Malie K Collins; Andrew Trecartin; Zhi Cheng; Philip K Frykman; Tracy C Grikscheit
Journal:  Tissue Eng Part A       Date:  2015-10-28       Impact factor: 3.845

Review 8.  Hirschsprung Disease beyond Infancy.

Authors:  Casey M Calkins
Journal:  Clin Colon Rectal Surg       Date:  2018-02-25

9.  Hirschsprung's disease associated with Down syndrome: a meta-analysis of incidence, functional outcomes and mortality.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

10.  Pan-enteric neuropathy and dysmotility are present in a mouse model of short-segment Hirschsprung disease and may contribute to post-pullthrough morbidity.

Authors:  Sukhada Bhave; Emily Arciero; Corey Baker; Wing Lam Ho; Richard A Guyer; Ryo Hotta; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2020-04-17       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.